OpenAlex
PricingAboutJobs
Log inGet started
Author

Priti Pednekar

Observed name: P Pednekar
Institution: Astellas Pharma (United States)
Observed institution: Astellas Pharma (United States)
OpenAlex ID: A5034195229
Treatment patterns among Medicare beneficiaries with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) during 2020-2024.
2026 · Ronald C. Chen, Kimberly Donnowitz, et al. · JCO Oncology Practice
PDF
Treatment patterns among US patients with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) during 2021–2024: Retrospective cohort study using the IQVIA database.
2026 · Ronald C. Chen, Kimberly Donnowitz, et al. · JCO Oncology Practice
PDF
Ee161 Healthcare Resource Utilization and Costs Associated With Transfusion Burden in Older Us Patients With Relapsed Flt3-mutated Acute Myeloid Leukemia Who Were Prescribed Gilteritinib: a Medicare Claims-based Cohort Study
2026 · Priti Pednekar, Alana Block, et al. · Value in Health
PCR15 Criteria for the Value Assessment for Medication Adherence-Enhancing Interventions
2024 · D Nayak, B Borah, et al. · Value in Health
HTA193 Criteria for Value Assessment of Medication Adherence-Enhancing Interventions: Preliminary Results of a Systematic Review
2022 · T Agh, M Hiligsmann, et al. · Value in Health
Works count: 5
Citation count:
H-index:
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security